Stay updated on Dolutegravir Study in Completing IMPAACT Participants Clinical Trial
Sign up to get notified when there's something new on the Dolutegravir Study in Completing IMPAACT Participants Clinical Trial page.

Latest updates to the Dolutegravir Study in Completing IMPAACT Participants Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page revision was updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedAdded Revision: v3.4.3 label; removed Revision: v3.4.2 label.SummaryDifference0.0%

- Check52 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; no substantive changes to study content or functionality observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check59 days agoChange DetectedThe page now includes updated results information (Results First Posted 2026-02-05, Results First Submitted 2026-01-14, and related QC–posted results) and new/updated study documents (Study Protocol and SAP) to accompany the study record.SummaryDifference2%

- Check81 days agoChange DetectedSite revision updated from v3.3.3 to v3.3.4 with no observable impact on content or functionality.SummaryDifference0.0%

- Check102 days agoChange DetectedAdded 'Results Submitted' status and a new 'Locations' section listing California, Florida, and Tennessee, replacing the previous state-location headings; the page now shows Revision: v3.3.3.SummaryDifference0.4%

Stay in the know with updates to Dolutegravir Study in Completing IMPAACT Participants Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dolutegravir Study in Completing IMPAACT Participants Clinical Trial page.